The role played by alternative splicing in antigenic variability in

Endo-parasites that affect humans include Plasmodium, the causative agent of malaria, which remains one of the leading causes of death in human beings. Despite decades of research, vaccines to this and other endo-parasites remain elusive. This is in part due to the hyper-variability of the parasites surface proteins. Generally these surface proteins are encoded by a large family of genes, with only one being dominantly expressed at certain life stages. Another layer of complexity can be introduced through the alternative splicing of these surface proteins. The resulting isoforms may differ from each other with regard to cell localisation, substrate affinities and functions. They may even differ in structure to the extent that they are no longer recognised by the host’s immune system. In many cases this leads to changes in the N terminus of these proteins. The geographical localisation of endo-parasitic infections around the tropics and the highest incidences of HIV-1 infection in the same areas, adds a further layer of complexity as parasitic infections affect the host immune system resulting in higher HIV infection rates, faster disease progression, and an increase in the severity of infections and complications in HIV diagnosis. This review discusses some examples of parasite surface proteins that are alternatively spliced in trypanosomes, Plasmodium and the parasitic worm Schistosoma as well as what role alternate splicing may play in the interaction between HIV and these endo-parasites.

INSPIRED Symposium Part 4B: Chimeric Antigen Receptor T Cell

Bioconjugation Approaches to Producing Subunit Vaccines Composed

Small variant surface antigens and Plasmodium evasion of immunity

The Expanding Landscape of Alternative Splicing Variation in Human

Dysregulation and therapeutic targeting of RNA splicing in cancer

The role of alternative splicing in cancer: From oncogenesis to

Diversification of antibodies after B-cells encounter antigen

TCR-engineered T cell therapy in solid tumors: State of the art

Frontiers Response: Commentary: An In Silico–In Vitro Pipeline

Non‐coding RNAs in malaria infection - Lodde - 2022 - WIREs RNA

Expression of human IgD by alternative splicing and CSR. (A) Ig

IJMS, Free Full-Text